Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Adenosine A2AR/A1R Antagonists Enabling Additional H3R Antagonism for the Treatment of Parkinson's Disease.
J Med Chem. 2021 Jun 24;64(12):8246-8262. doi: 10.1021/acs.jmedchem.0c00914. Epub 2021 Jun 9.
J Med Chem. 2021.
PMID: 34107215
Rasagiline derivatives combined with histamine H3 receptor properties.
Lutsenko K, Hagenow S, Affini A, Reiner D, Stark H.
Lutsenko K, et al. Among authors: affini a.
Bioorg Med Chem Lett. 2019 Oct 1;29(19):126612. doi: 10.1016/j.bmcl.2019.08.016. Epub 2019 Aug 9.
Bioorg Med Chem Lett. 2019.
PMID: 31421966
Item in Clipboard
Novel indanone derivatives as MAO B/H3R dual-targeting ligands for treatment of Parkinson's disease.
Affini A, Hagenow S, Zivkovic A, Marco-Contelles J, Stark H.
Affini A, et al.
Eur J Med Chem. 2018 Mar 25;148:487-497. doi: 10.1016/j.ejmech.2018.02.015. Epub 2018 Feb 16.
Eur J Med Chem. 2018.
PMID: 29477889
Item in Clipboard
Multiple Targeting Approaches on Histamine H3 Receptor Antagonists.
Khanfar MA, Affini A, Lutsenko K, Nikolic K, Butini S, Stark H.
Khanfar MA, et al. Among authors: affini a.
Front Neurosci. 2016 May 30;10:201. doi: 10.3389/fnins.2016.00201. eCollection 2016.
Front Neurosci. 2016.
PMID: 27303254
Free PMC article.
Review.
Item in Clipboard
Cite
Cite